Integrative Analyses of Genes Associated with Fulminant Type 1 Diabetes

Area of Science:

• Endocrinology
• Genetics
• Bioinformatics

Background:

• Fulminant type 1 diabetes (FT1D) is a severe subtype of type 1 diabetes characterized by rapid onset and metabolic derangement.
• Understanding the molecular underpinnings of FT1D is crucial for developing effective treatments.

Purpose of the Study:

• To identify critical genes and elucidate potential molecular mechanisms involved in FT1D.
• To screen for novel therapeutic targets for FT1D.

Main Methods:

• Downloaded and analyzed gene expression data (GSE44314) from FT1D patients and healthy controls.
• Utilized NetworkAnalyst for differential gene expression analysis, protein-protein interaction (PPI) network construction, and identification of microRNA (miRNA) and transcription factor (TF) regulatory networks.
• Performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses using DAVID.

Main Results:

• Identified 130 differentially expressed genes (DEGs) between FT1D patients and controls.
• GO analysis revealed enrichment in energy metabolism and mitochondrial functions.
• KEGG analysis highlighted involvement in nonalcoholic fatty liver disease pathways.
• Identified key hub genes in PPI, miRNA-target, and TF-target networks, including SRF, NCOA1, and ETS1.

Conclusions:

• Bioinformatic analysis of DEGs successfully pinpointed key genes and pathways associated with FT1D.
• The identified molecular mechanisms and genes provide a deeper understanding of FT1D pathogenesis.
• These findings may offer novel therapeutic strategies for managing FT1D.